View Latest Medical and Pharma Bids and Tenders

Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Bosutinib, Atc L01Ea04 (Obg) For The Period 01.10.2024 - 30.09.2026

Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Allergen Extract From Exclusively Timothy Grass Pollen (Excl. Sut), Atc V01Aa02 For The Period 01.10.24-30.09.26

Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Bimekizumab, Atc L04Ac21 (Obo) For The Period 01.10.2024 - 30.09.2026

Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Dapagliflozin, Atc A10Bk01 (Obo) For The Period 01.10.2024 - 30.09.2026

Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Allergen Extract From Timothy Grass, Sweetgrass, Etc. (Excl. Sut), Atc V01Aa02 For The Period 01.10.24-30.09.26

Open House Drug Discount Agreements Treprostinil, Atc B01Ac21

Open House Drug Discount Agreements Telmisartan, Atc C09Ca07

Open House Drug Rebate Agreements Febuxostat, Atc M04Aa03

Open House Drug Rebate Agreements Raltegravir, Atc J05Aj01

Open House Drug Discount Agreements Timolol And Latanoprost, Atc S01Ed61